Snapdragon Opens 51,000 sq. ft Boston-Area Facility for GMP Manufacturing & Process Development
Waltham, MA – May 9, 2022 – Snapdragon Chemistry’s newest facility opens Monday, May 9, 2022, for GMP manufacturing and process development. The new facility will greatly expand Snapdragon capacity for supplying clinical intermediates and drug substances.
While Massachusetts is well known as one of the world’s leading life sciences hubs, the focus has traditionally been on research and development rather than manufacturing. With the addition of four new GMP kilo-labs in the new facility, Snapdragon is a nimble partner to drug developers, accelerating the path to clinic.
Their expert staff of scientist and engineers are leveraging state-of-the-art computer and automation technology to rapidly solve complex process and analytical development challenges. Snapdragon uses deep process understanding afforded by data-rich experimentation to design and rapidly execute an efficient GMP manufacturing process.
With their GMP manufacturing facility right in the heart of the Massachusetts biotech hub, Snapdragon is the ideal collaboration partner to deliver innovator molecules to clinic.
About Snapdragon Chemistry
Snapdragon Chemistry specializes in active pharmaceutical ingredient (API) batch and continuous flow process development, utilizing state-of-the-art automation technology and proprietary equipment to solve complex process and analytical development challenges. With R&D and manufacturing headquartered in Waltham, Massachusetts, Snapdragon’s 70+ employees come with strong ties to the local scientific community, with 31 PhD scientists on staff. For more information, please contact firstname.lastname@example.org.